Tumor suppressor role of KiSS-1 in bladder cancer: Loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome

American Journal of Pathology

Volumn 162, Issue 2, 2003, Pages 609-617

  Sanchez Carbayo, Marta ^a   Capodieci, Paola ^a   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KISS 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL CYCLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PRIORITY JOURNAL; UROTHELIUM;

EID: 0037331838     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63854-0     Document Type: Article

References (37)

1. Cancer Facts and Figures 2000. American Cancer Society, 2000
2. Fidler IJ: Critical factors in the biology of human cancer metastasis. Cancer Res 1990, 50:6130-6138
3. Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Weissman BE, Standbridge EJ: Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 1994, 9:255-262
4. Miele ME, Robertson G, Lee JH, Coleman A, McGarry CT, Fisher PB, Lugo TG, Welch DR: Metastasis suppressed, but tumorigenicity and local invasiveness unaffected in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Mol Carcinog 1996, 15:284-299
5. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR: KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996, 88:1731-1737
6. Lee JH, Welch DR: Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using substractive hybridization and differential display. Int J Cancer 1997, 71:1035-1044
7. Lee JH, Welch DR: Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 1997, 57:2384-2387
8. West A, Votja PJ, Welch DR, Weissman BE: Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene. Genomics 1998, 54:145-148
9. Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M: Metastin receptor is overexpressed in papillary thyroid cancer and activated MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab 2002, 87:2399-2402
10. Yan C, Wang H, Boyd DD: KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. J Biol Chem 2001, 276:1164-1172
11. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M: Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001, 411:613-617
12. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brezillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001, 276:34631-34636
13. Hori A, Honda S, Asada M, Ohtaki T, Oda K, Watanabe T, Shintani Y, Yamada T, Suenaga M, Kitada C, Onda H, Kurokawa T, Nishimura O, Fujino M: Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 2001, 286:958-963
14. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC: AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001, 276:28969-28975
15. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G: Making and reading microarrays. Nat Genet 1999, 21:S15-S19
16. Stears RL, Getts RC, Gullans SR: A novel, sensitive detection system for high-density microarrays using dendrimer technology. Physiol Genomics, 2000, 3:93-99
17. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM: High-fidelity mRNA amplification for gene profiling. Nature Biotechnol 2000, 18:457-459
18. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868
19. Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985, 39:783-791
20. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DHY, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001, 158:1245-1251
21. American Joint Committee on Cancer: Staging of cancer at genito-urinary sites. American Joint Committee on Cancer: Manual for Staging of Cancer, ed 3. Philadelphia, J. B. Lippincott Co., 1988, pp 194-195
22. Mostofi FK: Histological Typing of Urinary Bladder Tumors. Geneva, World Health Organization, 1973
23. Capodieci P, Magi-Galluzi C, Moreira Jr G, Zeheb R, Loda M: Automated in situ hybridization: diagnostic and research applications. Diagn Mol Pathol 1998, 7:69-75
24. Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics, ed 2. Norwalk, Appleton & Lange, 1994
25. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537
26. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235
27. Shirasakii F, Takata M, Hatta N, Takehara K: Loss of expression of the metastasis suppressor gene KiSS-1 during melanoma progression and its association with LOH of chromosome 6q16.3q23. Cancer Res 2001, 61:7422-7425
28. Simon R, Burger H, Semjonov A, Hertle L, Terpe HJ, Becker W: Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol 2000, 17:1025-1029
29. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW, Sul CK: Detection of genetic alterations by comparative genomic hybridization and cytogenetics analysis. Cancer Genet Cytogenet 1999, 110:87-93
30. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L, Terpe HJ: Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998, 185:345-351
31. Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C: Genetic alterations in bladder cancer. Lancet 1993, 324:469-471
32. Reznikoff CA, Belair C, Savelieva E, Zhai Y, Pfeifer K, Yeager T, Thompson KJ, DeVries S, Bindley C, Newton MA: Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev 1994, 8:2227-2240
33. Markl ID, Jones PA: Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Res 1998, 58:5348-5353
34. Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C: Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin Cancer Res 2002, 8:171-179
35. Debies MT, Welch DR: Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia 2001, 6:441-451
36. Giroldi LA, Bringuier PP, Shimazui T, Jansen K, Schalken JA: Changes in cadherin-catenin complexes in the progression of human bladder carcinoma. Int J Cancer 1999, 82:70-76
37. Seraj MJ, Harding MA, Gildea JJ, Welch DR, Theodorescu D: The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis 2000, 18:519-525